FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090680 [Registered on: 10/07/2025] Trial Registered Prospectively
Last Modified On: 14/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Study on the effect of two Ayurvedic drugs Navakarshika Guggulu and Hardidrakhanda in people exposed to Hives. 
Scientific Title of Study   Comparative Clinical Study of Navakarshika Guggulu and Haridrakhanda in Sheetpitta (Urticaria) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Udita Kuria 
Designation  PG Scholar 
Affiliation  Patanjali Bharatiya Ayurvigan Evam Anusandhan Sansthan 
Address  Department of Kayachikitsa, Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar,Uttarakhand.

Hardwar
UTTARANCHAL
249405
India 
Phone  07457814478  
Fax    
Email  udita.kuria97@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vd Vikram Gupta 
Designation  Professor 
Affiliation  Patanjali Bharatiya Ayurvigan Evam Anusandhan Sansthan 
Address  Department of Kayachikitsa, Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar,Uttarakhand.

Hardwar
UTTARANCHAL
249405
India 
Phone  8958640973  
Fax    
Email  vdvikram20@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Vd Vikram Gupta 
Designation  Professor 
Affiliation  Patanjali Bharatiya Ayurvigan Evam Anusandhan Sansthan 
Address  Department of Kayachikitsa, Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar,Uttarakhand.

Hardwar
UTTARANCHAL
249405
India 
Phone  8958640973  
Fax    
Email  vdvikram20@gmail.com  
 
Source of Monetary or Material Support  
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar 249405, Uttarakhand, India 
 
Primary Sponsor  
Name  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan 
Address  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar-249405,Uttarakhand, India 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Udita Kuria  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar-249405, Uttarakhand, India
Hardwar
UTTARANCHAL 
07457814478

udita.kuria97@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L509||Urticaria, unspecified. Ayurveda Condition: SITAPITTAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Navakarshika Guggulu, Reference: Bhavaprakash Madhyakhand, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: -lukewarm water), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Haridrakhanda, Reference: Bhaishajya Ratnavali, Route: Oral, Dosage Form: Churna/ Powder, Dose: 4(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: -lukewarm water), Additional Information: -
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Patients willing to participate.
2. Patients with classical symptoms of urticaria.
3. Patients will be selected irrespective of gender and socio economic status. 
 
ExclusionCriteria 
Details  1. Patient having any systemic illness like tuberculosis, carcinoma and endocrine disorders or any major illness like renal or liver disorder.
2. Pregnant and lactating woman.
3. Patients consuming steroids on regular basis for any ailment. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Subjective parameters- Grading will be done considering signs and symptoms of sheetpitta-
1. Kotha (Raised skin,lesions,rashes)
2. Kandu (Itching sensation)
3. Toda (Pricking pain)
4. Daha (Burning sensation)
Objective Parameters-
1. No. of wheals
2. Intensityof pruritis
3. Duration of wheals
4. Freq. of appearance
5. Freq. of histamines
is assessed 
0day 30days 60days 
 
Secondary Outcome  
Outcome  TimePoints 
Subjective parameters- Grading will be done considering signs and symptoms of sheetpitta-
1. Kotha (Raised skin,lesions,rashes)
2. Kandu (Itching sensation)
3. Toda (Pricking pain)
4. Daha (Burning sensation)
Objective Parameters-
1. No. of wheals
2. Intensityof pruritis
3. Duration of wheals
4. Freq. of appearance
5. Freq. of histamines
is assessed 
0day 30days 60days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   21/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Open to Recruitment 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is an open label, double arm comparative study, comparing the efficacay of Navakarshika Guggulu 500mg twice daily after meal and Haridrakhanda 4 gm twice daily before meal in 60 patients with sheetpitta(urticaria) that will be conducted in Opd no. 13/14 iin Patanjali Ayurveda Hospital, Haridwar. Assessment will be done on the basis of subjective and objective parameters.

Route of administrarion- Oral route

Follow up- will be done to observe effects of treatment or any adverse effect on the patient.

1st follow up- 1 month after commencement of tratment
2nd follow up- 1 month after the 1st follow.
 
Close